🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan

Recruitingn/aAges any - anyAllKaohsiung Medical University Chung-Ho Memorial Ho…
NCT03200379 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1\. Patients who are treated with DAA and have willingness to participate in this registry. Exclusion Criteria: Chronic hepatitis C patients who are unwilling to participate in the study and do not provide written informed consent for participation.
💊

What it tests

  • directly acting antivirals (DAAs)
📍

Where

1 site
HepatobiliaryDivision, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Kaohsiung City, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy